European Post-Approval Safety Study (EU Pass) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety In Patients (Pts) Treated With Pomalidomide (POM)

Bibliographic Details
Title: European Post-Approval Safety Study (EU Pass) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety In Patients (Pts) Treated With Pomalidomide (POM)
Authors: Di Raimondo, Francesco, Kyriakou, Charalampia, Schmidt-Hieber, Martin, Vekemans, Marie-Christiane, Payer, Angel Ramirez, Bentsen, Pal Tore, Lauri, Birgitta, Kueenburg, Elisabeth, Atiba-Davies, Margaret, Lersch, Frederik, Rosettani, Barbara, Bacon, Pamela, Plesner, Torben
Source: In Clinical Lymphoma Myeloma and Leukemia February 2017 17(1) Supplement:e62-e62
Database: ScienceDirect
More Details
ISSN:21522650
DOI:10.1016/j.clml.2017.03.113
Published in:Clinical Lymphoma Myeloma and Leukemia
Language:English